Valentina Boni

机构：Hospital Universitario Quirónsalud Madrid, IDCQ Hospitales y Sanidad, S.L.U. · ORCID：0000-0002-8675-0018

发表论文 460 篇 · 总被引 10947 次 · h-index 42

代表论文

• Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1) (2024 · Journal for ImmunoTherapy of Cancer · 被引 33)
• Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial (2025 · Nature Medicine · 被引 23)
• Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER study (2024 · Gynecologic Oncology · 被引 11)
• Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial (2025 · Journal for ImmunoTherapy of Cancer · 被引 7)
• Abstract CT204: Phase 1a/b study of runimotamab, a HER2 x CD3 T cell-engaging bispecific antibody, administered as a single agent and in combination with trastuzumab in patients with HER2-expressing breast cancer (BC) (2025 · Cancer Research · 被引 7)
• Abstract P4-10-21: Enhanced anti-tumor activity of zelenectide pevedotin in triple negative breast cancer (TNBC) patients (pts) with NECTIN4 gene amplification (amp) (2025 · Clinical Cancer Research · 被引 5)